Using several innovative delivery methods, the new consortium – including researchers Krishanu Saha, Sarah Gong, David Gamm, Bikash Pattnaik and T. Michael Nork – will move ahead with gene editing techniques to treat two rare blinding diseases, Best disease and Leber congentital amaurosis (LCA). Read more.
